Apollomics Inc.
APLM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001944885
In the last 90 days, Apollomics Inc. insiders filed 3 open-market purchases and 0 sales; 4 institutions reported holding it in 13F filings for Q2 2026, worth $223.8K in total; no superinvestor holds it.
Other share classesAPLMW
Q3 2024 vs. Q2 2024
How the institutions holding Apollomics Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 10 | 1 | 11 | +2 |
| Shares | 10.0M | 86 | 2.27M | −7.73M (−77.3%) |
| Value | $2.11M | $18 | $323.1K | −$1.78M (−84.7%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (5)
Institutions that held Apollomics Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 131,539 | $18.7K | 0.00% |
| XTX Topco Ltd | 68,171 | $9.69K | 0.00% |
| Warberg Asset Management LLC | 23,513 | $3.34K | 0.00% |
| Jane Street Group, LLC | 13,391 | $1.90K | 0.00% |
| BlackRock, Inc. | 86 | $12 | 0.00% |
Sold out (3)
Institutions that held Apollomics Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| OrbiMed Advisors LLC | 8,565,456 | $1.81M |
| George Kaiser Family Foundation | 670,976 | $140.9K |
| Renaissance Technologies LLC | 57,100 | $12.0K |
Not filed for Q3 2024 yet (1)
Institutions that held Apollomics Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 86 | $18 |